Early use of mycophenolate mofetil (MMF), a drug used to dampen the immune system in organ transplant recipients, may reduce the risk for severe flares in patients with newly diagnosed systemic lupus ...

Please provide your email address to receive an email when new articles are posted on . MMF demonstrated comparable safety and greater reductions in AST and ALT vs. azathioprine in autoimmune ...

Patients with dermatologic conditions showed a 74% lower risk for malignancy with mycophenolate mofetil (MMF) than transplant patients, a study found. Researchers conducted a single-center ...

Belimumab showed efficacy in a subgroup of patients with lupus nephritis treated with MMF as standard of care background therapy. Belimumab reduces proteinuria in patients with class 3 or 4 lupus ...